Wissam Abouzgheib, MD
Pulmonary Disease · Camden, NJNPI 1841246451
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.7%), education and consulting fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Boston Scientific at 41.8% of the total. 2024 is the largest year on record at $23,833, 3.7 times the $6,527 reported in 2019. Among pulmonary disease clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 103 payments — averaging $434.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$19K
- Intuitive Surgical$19K
- Olympus Medical Systems Corporation$4K
- Olympus America Inc.$2K
- Gyrus ACMI, Inc.$365
- Olympus Corporation$163
- plus $190 from 9 others
What the payments were for
- Consulting fees$7,70317%
- Speaking & faculty fees$18,65042%
- Travel & lodging$4,0709%
- Food & beverage$2,8336%
- Education$11,45026%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 27 | $18,676 |
| Intuitive Surgical | 41 | $18,633 |
| Olympus Medical Systems Corporation | 8 | $4,391 |
| Olympus America Inc. | 12 | $2,287 |
| Gyrus ACMI, Inc. | 1 | $365 |
| Olympus Corporation | 2 | $163 |
| Novartis | 3 | $46 |
| Genentech USA, Inc. | 2 | $33 |
| GSK | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| ERBE USA Inc | 1 | $15 |
| Pfizer | 1 | $15 |
| Mylan Specialty L.p. | 1 | $15 |
| Boehringer Ingelheim | 1 | $12 |
| Veran Medical Technologies, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$14,643
- DAVINCI XI$3,000
- Olympus Bronchoscopes$1,500
- GENERAL PULMONARY$1,275
- Spiration Valve System$365
- SPiN Vision Video Processor$365
- DA VINCI SP$265
How this compares
$44,705 in reported general payments places this provider in the 95th percentile of 472 pulmonary disease providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Incruse ElliptaUmeclidinium Bromide | 15 | $5,384 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $381 |
| Montelukast Sodium | 12 | $74 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKIncruse Ellipta | $26 | $5,38415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 472 pulmonary disease providers in New Jersey.
Other pulmonary disease in Camden
- Joseph HoffmanPark Ridge$1.1M
- Reynold PanettieriNew Brunswick$1M
- Robert SussmanSummit$551K
- Manuel CunananMillville$489K
- Emanuele SantomauroHackensack$420K
- Richard MillerNewark$328K
- Jason ShatkinParamus$282K
- Anthony RickettiTrenton$225K
- Jeffrey MiskoffManasquan$176K
- Peter SacconeLinwood$149K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.